Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Application Number 16006473

16006473
Not Appealed
Patent NumberUS 10138299 B2
Publication NumberUS 20180282413 A1
Filled DateJun 12, 2018
Priority DateMay 15, 2012
Inventor/ApplicantsStacie M. Goldberg
Xi-Tao Wang
Maria JURE-KUNKEL
Ashok K. Gupta
Ashok K. GUPTA
Stacie M. GOLDBERG
John P. Cogswell
Maria Jure-Kunkel
Xi-Tao WANG
Jon M. Wigginton
John P. COGSWELL
Jon M. WIGGINTON
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Assignments
Bristol Myers Squibb
Current
Bristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.